About Imatinib Mesylate Tablets Imatinib Mesylate Tablets are prescription oncology medicines belonging to the tyrosine kinase inhibitor (TKI) class. They are widely used in specialized oncology and hematology treatment programs under the supervision of qualified medical professionals. The tablets are manufactured following stringent pharmaceutical quality standards and supplied to regulated healthcare markets through licensed distribution networks. Product Profile Specification: Information Generic Name: Imatinib Mesylate Dosage Form: Oral Tablets Available Strengths: 100 mg & 400 mg Therapeutic Category: Oncology Medicine Drug Class: :Tyrosine Kinase Inhibitor (TKI) Prescription Status: Prescription Only Country of Origin: India Medical Applications: Hematology treatment programs Oncology management protocols Long-term physician-supervised therapy Hospital cancer care services Specialized oncology clinics Clinical treatment pathways Safety & Clinical Guidance: Use the medicine only under medical supervision. Attend scheduled follow-up appointments. Inform healthcare providers about existing medical conditions and concurrent medications. Follow laboratory monitoring recommendations when advised. Report unusual symptoms promptly to the treating physician. Why Choose Our Pharmaceutical Export Services: Consistent international product availability Bulk supply for institutional buyers Experienced pharmaceutical export team Timely worldwide dispatch Complete export documentation support Quality-focused sourcing network Competitive commercial pricing Regulatory & Export Documentation Certificate of Analysis (COA) Certificate of Origin (COO) Commercial Invoice Packing List Batch Certificate Product Specification Sheet Manufacturing Compliance Docum Imatinib Mesylate Tablets 100 mg Imatinib Mesylate Tablets 400 mg Dasatinib Tablets Nilotinib Capsules Bosutinib Tablets Ponatinib Tablets Erlotinib Tablets Gefitinib Tablets Frequently Asked Questions 1. Which strengths of Imatinib Mesylate Tablets are available for export? The commonly supplied strengths are 100 mg and 400 mg, subject to manufacturer availability and destination market requirements. 2. Who can place bulk orders for Imatinib Mesylate Tablets? Licensed pharmaceutical importers, hospitals, oncology distributors, government procurement agencies, and authorized healthcare wholesalers can procure bulk quantities. 3. Are export documents provided with international shipments? Yes. Eligible orders can be accompanied by COA, COO, CPP (where applicable), commercial invoices, packing lists, batch documentation, and other required regulatory documents. 4. Which countries frequently source Imatinib Mesylate Tablets? Demand is strong in the United States (Washington, D.C.), United Kingdom (London), Australia (Canberra), Canada (Ottawa), Singapore, France (Paris), Germany (Berlin), UAE (Abu Dhabi), Saudi Arabia (Riyadh), South Africa (Pretoria), and Nigeria (Abuja). 5. Why do global healthcare buyers choose Indian exporters for Imatinib Mesylate Tablets? Indian pharmaceutical exporters are recognized for supplying quality-assured oncology medicines, dependable bulk availability, competitive commercial pricing, regulatory documentation support, and efficient worldwide distribution tailored to institutional healthcare procurement. #ImatinibMesylate #Imatinib100mg #Imatinib400mg #TyrosineKinaseInhibitor #TargetedTherapy #OncologyMedicine #CancerCare #PharmaceuticalExporter #WholesaleMedicines #HospitalPharmacy #MedicineSupplier #IndianPharma #BulkMedicine #HealthcareDistributor #GlobalHealthcare #MedicalImports #OncologyExport #HealthcareProcurement #CancerMedicineSupplier #ErnestPharmaceutical Online Imatinib Mesylate Tablets Imatinib Mesylate Tablets Supplier India Wholesale Imatinib Tablets Buy Imatinib 100 mg Tablets Imatinib 400 mg Tablet Exporter Tyrosine Kinase Inhibitor Supplier Oncology Tablet Export Company Bulk Cancer Medicine Supplier Pharmaceutical Exporter India 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1

Product Introduction Fulvestrant Injection 250mg/5mL is a sterile hormonal anticancer medicine used in the treatment of selected hormone receptor-positive breast cancers. It belongs to the estrogen receptor antagonist (SERD) class and works by blocking and reducing estrogen receptors that may promote the growth of certain breast cancer cells. Product Profile Specification Details Generic Name:Fulvestrant Strength:250mg/5mL Dosage Form:Sterile Injection Medicine Category:Hormonal Anticancer Medicine Drug Class:Selective Estrogen Receptor Degrader (SERD) Route of Administration:Intramuscular Injection Prescription Status:Prescription Only Primary Users:Hospitals & Oncology Centers Export Availability:Bulk & Commercial Supply Country of Origin: India In Case of Emergency or Overdose Seek immediate medical attention. Monitor the patient for worsening adverse effects and overall clinical condition. Supportive medical care should be provided based on symptoms. Inform the treating oncologist about the amount administered and the timing of the dose. Patients should never attempt to self-inject or adjust treatment schedules. Other Uses for This Medicine Besides its approved indications, healthcare professionals may consider Fulvestrant for certain specialized treatment strategies based on current clinical guidelines and patient-specific factors. In some cases, oncologists may combine it with other targeted anticancer medicines where clinically appropriate. What Side Effects Can This Medication Cause?: Frequently Reported Effects Injection-site discomfort Nausea Fatigue Headache Joint or muscle pain Mild weakness Unusual bleeding Persistent swelling of the legs Difficulty breathing or chest discomfort Global Demand for Hormonal Oncology Medicines Continues to Rise: Breast cancer treatment programs continue expanding worldwide, increasing procurement of hormone-based injectable medicines across North America, Europe, the Middle East, and Asia-Pacific. Frequently Asked Questions 1. What is Fulvestrant Injection 250mg/5mL primarily used for? It is prescribed for selected patients with hormone receptor-positive breast cancer as part of specialist-directed hormonal treatment. 2. Who should administer Fulvestrant Injection? Only qualified healthcare professionals should administer the injection in hospitals or oncology clinics. 3. Can hospitals order Fulvestrant Injection in bulk? Yes. Licensed hospitals, oncology centers, pharmaceutical distributors, and government procurement agencies may purchase commercial quantities subject to applicable regulations. 4. What export documents are generally available? Eligible international orders may include documents such as the Certificate of Analysis (COA), Certificate of Origin (COO), Commercial Invoice, Packing List, and other export-related documentation. 5. Why is India a preferred source for Fulvestrant Injection? India is recognized for high-quality pharmaceutical manufacturing, competitive pricing, scalable production capacity, and reliable international export support. -Buy Fulvestrant Injection 250mg 5mL Online -Fulvestrant Injection Supplier USA -Fulvestrant Exporter India -Hormonal Cancer Injection Supplier -Breast Cancer Medicine Export -Fulvestrant Wholesale Distributor -Oncology Injection Supplier -Injectable Breast Cancer Medicine -Pharmaceutical Export Company India -Hospital Oncology Procurement 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #FulvestrantInjection #Fulvestrant250mg #BreastCancerMedicine #HormonalTherapy #OncologyInjection #CancerCare #USAHealthcare #WashingtonDCMedical #HospitalProcurement #IndianPharmaExporter #GlobalPharma #BulkMedicineSupplier #HealthcareDistribution #OncologySupplier #MedicalExports #CancerTreatment #PharmaceuticalExporter #WorldwideHealthcare #LicensedMedicineSupplier #ErnestPharmaceutical

🌍 Global Supply Overview Modern oncology treatment requires targeted therapies that support precision medicine. Erlotinib Tablets BP 100mg and 150mg are prescription medicines supplied to licensed pharmaceutical importers, oncology hospitals, distributors, and government healthcare organizations across international markets. Ernest Oncology provides dependable export solutions for institutional buyers seeking quality oncology medicines from India. 💊 Product Identity Specification Details Brand Category: Erlotinib Tablets BP Available Strengths: 100 mgg & 150mg Medicine Type: Targeted Anticancer Therapy Dosage Form: Oral Tablets Therapeutic Class: Epidermal Growth Factor Receptor (EGFR) Inhibitor Supply Mode: Bulk Supply • Export • Distribution Country of Origin: India 🎯About Erlotinib Tablets Erlotinib Tablets BP are prescription oncology medicines developed for patients whose treatment plan includes targeted EGFR inhibition. Unlike traditional chemotherapy medicines, Erlotinib focuses on blocking specific molecular pathways associated with cancer cell growth. The medicine is prescribed only when clinically appropriate and should be taken exactly as directed by an oncology specialist. 🩺 Clinical Applications Depending on approved indications and physician assessment, Erlotinib Tablets may be prescribed for: Advanced Non-Small Cell Lung Cancer (NSCLC) Pancreatic Cancer (in selected combination regimens) EGFR-positive cancer treatment protocols Long-term oral oncology management where clinically appropriate 🚀 What Makes Erlotinib Valuable? Precision-Focused Therapy Designed to target specific cancer cell pathways rather than broadly affecting rapidly dividing cells. Oral Administration Tablet formulation allows convenient treatment under medical supervision without routine intravenous administration. Global Clinical Acceptance Recognized in multiple international oncology treatment guidelines for approved indications. Institutional Procurement Frequently sourced by oncology hospitals, cancer centers, and licensed pharmaceutical distributors. Reliable Export Availability Available for international procurement through authorized pharmaceutical exporters from India. 📦 Export Advantages for International Buyers International procurement teams often evaluate suppliers based on more than product availability. Ernest Oncology supports buyers with: ✔ Bulk order fulfillment ✔ International export documentation ✔ Professional export packaging ✔ Multi-country shipping support ✔ Procurement assistance ✔ Dedicated buyer communication ❓ Quick Buyer Questions 1. What should international buyers verify before importing Erlotinib Tablets BP? Before placing an order, licensed importers should verify the product specifications, available strengths (100mg or 150mg), shelf life, packaging details, required export documentation, manufacturer compliance, and destination-country import regulations. Confirming these details in advance helps ensure a smooth procurement and customs clearance process. 2. Which tablet strengths are commonly available? Erlotinib tablets BP are commonly supplied in 100 mg and 150 mg strengths. 3. Who usually purchases this medicine? Hospitals, oncology centers, pharmaceutical distributors, wholesalers, NGOs, and government procurement agencies. 4. Can Ernest Oncology support export shipments? Yes. Ernest Oncology provides export support, documentation assistance, and international logistics coordination for eligible buyers. 5. Is a prescription required? Yes. Erlotinib tablets are prescription-only medicines and should be used strictly under the supervision of qualified oncology specialists. Erlotinib Tablets BP 100mg Supplier India Erlotinib Tablets BP 150mg Exporter Buy Erlotinib Tablets Wholesale Targeted Cancer Medicine Supplier EGFR Inhibitor Tablets Export Oncology Tablet Distributor Pharmaceutical Export Company India Bulk Oncology Medicine Supplier International Cancer Medicine Exporter Ernest Oncology India#ErlotinibWorldwide #PrecisionOncologySupply #TargetedTherapyExports #OralCancerMedicine #GlobalOncologyPartners #HospitalMedicineSource #InstitutionalDrugSupply #WorldwideCancerCare #InternationalPharmaBridge #TrustedOncologyExports #HealthcareImportNetwork #BulkTabletSupplier #AdvancedOncologyProducts #GlobalMedicineDistribution #LicensedHealthcareSupply #CancerMedicinePartners #IndiaPharmaGateway 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologuymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1

Oncology Medicine Exporter from India Introduction to Cetuximab Injection 100mg Cetuximab Injection 100mg is a targeted monoclonal antibody therapy used in modern oncology to treat selected EGFR (Epidermal Growth Factor Receptor)-positive cancers. Unlike conventional chemotherapy, Cetuximab specifically targets cancer cell receptors that promote tumor growth, helping slow disease progression while preserving many healthy cells. As a temperature-controlled injectable medicine, Cetuximab is administered only by qualified healthcare professionals in hospitals or specialized oncology centers. Ernest Impex supplies high-quality oncology medicines to licensed importers, hospitals, distributors, and healthcare procurement agencies across Singapore, France, and international markets. Medical Benefits Specifically targets EGFR-positive cancer cells Supports precision oncology treatment protocols Used in combination with chemotherapy or radiotherapy where clinically appropriate Widely utilized in colorectal cancer management Important treatment option for head and neck cancers Helps inhibit tumor cell growth and spread Manufactured under international pharmaceutical quality standards Suitable for hospital and institutional oncology procurement Drug Interactions Before receiving Cetuximab, healthcare providers should review all current medications. Possible interactions include: Platinum-based chemotherapy medicines Fluorouracil (5-FU) Irinotecan Oxaliplatin Immunosuppressive medicines Live vaccines Prescription medicines affecting immune response Herbal supplements and high-dose antioxidant products Patients should never start or stop any medicine without medical advice during cancer treatment. Buy Cetuximab Injection 100mg Online Cetuximab Injection Exporter India Cetuximab Supplier Singapore Cetuximab Distributor France EGFR Targeted Therapy Supplier Oncology Injection Export Company Cancer Injection Manufacturer India Monoclonal Antibody Exporter Cetuximab Wholesale Supplier Hospital Oncology Medicine Supplier Pharmaceutical Export from India Cancer Medicine Bulk Supplier Biologic Injection Export Oncology Drug Distributor Cetuximab Procurement Partner Frequently Asked Questions (FAQs) 1. What is Cetuximab Injection used for? It is used in selected EGFR-positive colorectal cancer and head & neck cancer treatment protocols. 2. Who should administer Cetuximab? Only trained healthcare professionals in hospitals or oncology clinics. 3. Is Cetuximab a chemotherapy medicine? No. It is a targeted monoclonal antibody therapy that works differently from traditional chemotherapy. 4. Can Ernest Impex export Cetuximab internationally? Yes. Ernest Impex supplies oncology medicines to licensed importers and distributors worldwide, subject to local regulations. 5. What documents are available for export? Depending on product availability and destination requirements, documentation may include COA, Batch COA, Product Information, Commercial Invoice, Packing List, and other export-related documents. #CetuximabInjection100mg #EGFRTargetedTherapy #MonoclonalAntibodyExport #PrecisionOncologyMedicine #BiologicCancerTreatment #TargetedCancerInjection #HospitalOncologySupply #GlobalCancerMedicine #InternationalPharmaTrade #CancerDrugProcurement #OncologyBiologics #SpecialtyInjectionExport #HealthcareImportSolutions #LicensedPharmaDistributor#IndianBiopharmaExports #CancerCareWorldwide #AdvancedOncologyTherapy #HospitalMedicineSupplier #BulkBiologicMedicines 🚚 International Oncology Medicine Distribution Network [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Wholesale Supply | Global Export | Pharmaceutical Partner 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1

The Comprehensive Guide to Pazopanib 200mg Tablets In the advanced treatment of solid tumors, Pazopanib 200mg Tablets have emerged as a critical targeted therapy. As a leading pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this vital medication is available to oncology centers and patients in London, New York, Sydney, Johannesburg, and beyond. Product Specifications Brand Name: Ernest-Oncology (Pazopanib Hydrochloride) Strength: 200 mg per tablet Dosage Form: Oral Film-Coated Tablet Primary Indications: Advanced Renal Cell Carcinoma (RCC) and Advanced Soft Tissue Sarcoma (STS) Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) Mechanism of Action: How It Works Anti-Angiogenesis: It inhibits Vascular Endothelial Growth Factor Receptors (VEGFR-1, -2, and -3), effectively “starving“ the tumor by preventing the formation of new blood vessels. Signal Disruption: It targets Platelet-Derived Growth Factor Receptors (PDGFR) and Fibroblast Growth Factor Receptors (FGFR), which are involved in cell growth and tumor stability. Inhibiting Proliferation: By blocking c-Kit and other tyrosine kinases, it stops the uncontrolled division of malignant cells.Anti-Angiogenesis: It inhibits Vascular Endothelial Growth Factor Receptors (VEGFR-1, -2, and -3), effectively “starving“ the tumor by preventing the formation of new blood vessels. Signal Disruption: It targets Platelet-Derived Growth Factor Receptors (PDGFR) and Fibroblast Growth Factor Receptors (FGFR), which are involved in cell growth and tumor stability. Inhibiting Proliferation: By blocking c-Kit and other tyrosine kinases, it stops the uncontrolled division of malignant cells. Therapeutic Indications & Administration Advanced Renal Cell Carcinoma (RCC): For patients with advanced kidney cancer. Advanced Soft Tissue Sarcoma (STS): For patients who have received prior chemotherapy. Administration Guidelines:Dosage: The standard recommended adult dose is 800 mg (four 200mg tablets) taken once daily. Food Restrictions: CRITICAL: Pazopanib must be taken on an empty stomach—at least 1 hour before or 2 hours after a meal. Taking it with food can significantly increase absorption to toxic levels. Whole Dose: Tablets should be swallowed whole with water; do not crush or chew them. Clinical Side Effects & Safety Hepatotoxicity: Pazopanib carries a “black box“ warning for severe and potentially fatal liver damage. Regular liver function tests (ALT, AST, and Bilirubin) are mandatory. Hypertension: High blood pressure is very common and must be managed with anti-hypertensive therapy. GI Issues: Diarrhea, nausea, vomiting, and decreased appetite. Cardiac Risks: Potential for QT prolongation (irregular heart rhythm) and cardiac dysfunction. Appearance Changes: Changes in hair color (depigmentation) or skin lightening. Why Source from Ernest Oncology? United Kingdom (London): Providing cost-effective alternatives for NHS and private oncology centers. USA: Supplying bulk quantities that meet stringent safety and documentation benchmarks. Australia: Facilitating access via the “Special Access Scheme“ (SAS) and other regulatory pathways. South Africa: Bridging the gap in cancer care with high-tier pharmaceutical exports from India 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Thalidomide 100mg Capsule: Immunomodulatory and Anti-Angiogenic Therapy for Multiple Myeloma and ENL Are you searching for a reliable Thalidomide 100mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted immunomodulatory agents. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Thalidomide 100mg? Thalidomide 100mg is an oral therapeutic agent containing the active pharmaceutical ingredient Thalidomide. Once known primarily for other uses, it has been repurposed as a powerful Immunomodulatory Drug (IMiD). It is a cornerstone in the treatment of plasma cell dyscrasias and specific inflammatory conditions. Due to its potent nature, it is distributed under strict regulatory oversight to ensure patient safety and therapeutic efficacy. 1. Therapeutic Indications Multiple Myeloma: Used in combination with Dexamethasone for patients with newly diagnosed multiple myeloma. It is also utilized in relapsed or refractory cases. Erythema Nodosum Leprosum (ENL): An essential treatment for the cutaneous manifestations of moderate to severe ENL (a complication of leprosy). It is also used as maintenance therapy to prevent and limit the recurrence of skin lesions. Off-Label Oncology Use: Occasionally utilized in research-backed protocols for specific solid tumors and myelodysplastic syndromes where anti-angiogenic properties are required. 2. Mechanism of Action: Multi-Faceted Attack Immunomodulation: It alters the production of cytokines, specifically inhibiting Tumor Necrosis Factor-alpha (TNF-α), which is a key driver of inflammation and cancer cell survival. Anti-Angiogenesis: It blocks the formation of new blood vessels (angiogenesis) by interfering with growth factors like VEGF and bFGF. This effectively “starves“ tumors of the nutrients needed to expand. Direct Anti-Tumor Effect: It induces cell cycle arrest and apoptosis (programmed cell death) in malignant plasma cells by disrupting their interaction with the bone marrow microenvironment. 3. Administration and Dosing Management Standard Dosing: For Multiple Myeloma, the typical dose ranges from 100mg to 200mg daily. For ENL, dosing is adjusted based on the severity of the reaction. Timing: It is generally recommended to take the capsule once daily at bedtime, at least 1 hour after the evening meal, to minimize sedation. Safety Handling: Capsules must be swallowed whole. Healthcare providers and caregivers should handle the medication with caution; direct contact with the powder inside the capsule should be avoided. Clinical Side Effects & Safety Monitoring eratogenicity (Birth Defects): This is the most critical risk. Thalidomide must never be used by pregnant women. Male and female patients must strictly adhere to specialized Risk Evaluation and Mitigation Strategies (REMS). Peripheral Neuropathy: Potential for tingling, numbness, or pain in the hands and feet. Early detection is vital to prevent permanent nerve damage. Venous Thromboembolism (VTE): Increased risk of blood clots (DVT or Pulmonary Embolism), especially when combined with steroids. Prophylactic blood thinners are often prescribed. Drowsiness & Sedation: Patients are advised to avoid heavy machinery or driving until their reaction to the drug is known. Why Source Thalidomide 100mg from Ernest Oncology? Verified Authenticity: Direct sourcing of high-integrity Thalidomide with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Capegard 500mg Tablet (Capecitabine) – Global Supplier & Exporter | Ernest Oncology Capegard 500mg Tablet Capegard 500mg Tablet contains Capecitabine, an oral chemotherapy medicine used in the treatment of several cancers including breast cancer, colorectal cancer, and gastric cancer. It belongs to the class of antimetabolite chemotherapy medicines and works by slowing or stopping the growth of cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Capegard 500mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Capegard 500mg Tablet? Capegard 500mg Tablet is an oral chemotherapy drug that is converted in the body into 5-fluorouracil (5-FU), a powerful anti-cancer agent. It interferes with DNA synthesis in cancer cells, preventing them from multiplying and spreading. Because it is taken orally, Capecitabine provides a convenient alternative to certain intravenous chemotherapy treatments. Mechanism of Action Capecitabine works as a prodrug of 5-fluorouracil (5-FU). Its mechanism includes: • Conversion into active 5-FU in tumor tissues • Inhibition of DNA synthesis in cancer cells • Blocking tumor cell growth and replication • Slowing progression of cancer This targeted activation helps increase effectiveness while reducing systemic toxicity. Indications Capegard 500mg Tablet is used for the treatment of: • Breast Cancer • Colorectal Cancer • Metastatic Colorectal Cancer • Gastric (Stomach) Cancer It may be used alone or in combination with other chemotherapy medicines. Dosage & Administration Typical dosage guidelines: • Dosage depends on body surface area and medical condition • Usually taken twice daily after meals • Tablets should be swallowed with water Treatment should be taken under the supervision of an oncologist. Key Benefits of Capegard 500mg Tablet ✔ Effective oral chemotherapy treatment ✔ Helps control tumor growth ✔ Convenient alternative to intravenous chemotherapy ✔ Used in combination cancer therapy ✔ Improves cancer treatment outcomes Possible Side Effects Some patients may experience: • Nausea • Vomiting • Diarrhea • Fatigue • Hand-foot syndrome • Loss of appetite Patients should be monitored regularly during treatment. Product Specifications Product Name: Capegard Generic Name: Capecitabine Strength: 500 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Antimetabolite Chemotherapy Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Capegard 500mg tablets worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Jemperli 500mg Injection (Dostarlimab) – Global Supplier & Exporter | Ernest Oncology Jemperli 500mg Injection Jemperli 500mg Injection contains Dostarlimab, an advanced immunotherapy medicine used in the treatment of certain types of endometrial cancer and other solid tumors. It belongs to the class of PD-1 immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Jemperli 500mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Jemperli 500mg Injection? Jemperli is a monoclonal antibody immunotherapy designed to treat cancers with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) characteristics. The medicine works by activating the immune system to detect and destroy cancer cells. This targeted immunotherapy helps improve treatment outcomes for patients with advanced cancers. Mechanism of Action Dostarlimab works by blocking the Programmed Death-1 (PD-1) receptor found on immune cells. Its mechanism includes: • Blocking the PD-1 immune checkpoint pathway • Enhancing immune system response against cancer cells • Restoring the body’s ability to detect and destroy tumor cells • Slowing cancer growth and progression Indications Jemperli 500mg Injection is used for the treatment of: • Endometrial Cancer with dMMR or MSI-H • Advanced or Recurrent Endometrial Cancer • Certain solid tumors with mismatch repair deficiency It is generally used when cancer has progressed after other treatments. Dosage & Administration Typical dosage guidelines: • 500 mg administered intravenously every 3 weeks • Later adjusted to 1000 mg every 6 weeks depending on treatment protocol • Given as an IV infusion in hospital or clinical settings Treatment should be administered under the supervision of an oncologist. Key Benefits of Jemperli 500mg Injection ✔ Advanced immunotherapy for cancer treatment ✔ Activates the immune system to fight cancer ✔ Effective for dMMR / MSI-H tumors ✔ Helps control tumor progression ✔ Targeted monoclonal antibody therapy Possible Side Effects Some patients may experience: • Fatigue • Nausea • Diarrhea • Skin rash • Fever • Immune-related reactions Patients should be monitored regularly during treatment. Product Specifications Product Name: Jemperli Generic Name: Dostarlimab Strength: 500 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Immunotherapy / PD-1 Inhibitor Packaging: Vial Storage: Store in refrigerator (2°C – 8°C), do not freeze Ernest Oncology supplies Jemperli 500mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites. www.ernestoncology.com www.oncologymedicinesupplier.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Eurolide 4ML (Leuprolide) Injection – Global Supplier & Exporter | Ernest Oncology Eurolide 4ML Leuprolide Injection – Hormone Therapy for Prostate Cancer & Endometriosis Eurolide 4ML Injection (Leuprolide Acetate) is a widely used hormonal therapy medicine prescribed for the treatment of prostate cancer, endometriosis, uterine fibroids, and hormone-dependent conditions. It belongs to a class of medicines called GnRH agonists (Gonadotropin-Releasing Hormone agonists) that help regulate hormone production in the body. Ernest Oncology a trusted pharmaceutical exporter from India, supplies Eurolide 4ML (Leuprolide) Injection to international healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. Hospitals, oncology centers, gynecology clinics, pharmaceutical distributors, and healthcare procurement companies import this medicine from Ernest Oncology for reliable global supply. What is Eurolide 4ML (Leuprolide) Injection? Eurolide 4ML contains Leuprolide Acetate, a synthetic hormone that works by reducing the production of certain hormones in the body such as testosterone and estrogen. This medicine is widely used in oncology and gynecology treatments to manage hormone-dependent diseases. Leuprolide therapy helps slow disease progression and manage symptoms related to hormone imbalance. Mechanism of Action Leuprolide works by acting on the pituitary gland and suppressing the release of gonadotropins, which reduces hormone levels in the body. Key pharmacological actions include: • Reduces testosterone production in men • Reduces estrogen production in women • Slows growth of hormone-dependent tumors • Helps control symptoms of hormonal disorders Because of this targeted hormonal action, Leuprolide injections are widely used in oncology and reproductive medicine worldwide. Medical Uses of Eurolide 4ML Injection Doctors prescribe Eurolide injection for several medical conditions including: Prostate Cancer Leuprolide is widely used in the treatment of advanced prostate cancer by reducing testosterone levels that promote tumor growth. Endometriosis Helps reduce pelvic pain and abnormal tissue growth associated with endometriosis. Uterine Fibroids Used to shrink fibroids before surgery and manage symptoms. Precocious Puberty Sometimes used to treat early puberty in children. Benefits of Eurolide 4ML (Leuprolide) Injection • Effective hormone therapy for prostate cancer • Helps control hormone-dependent diseases • Reduces tumor growth signals • Improves treatment outcomes in oncology patients • Widely used in gynecology and reproductive medicine • Trusted therapy in modern medical treatment protocols Product Information Product Name: Eurolide Injection Generic Name: Leuprolide Acetate Strength: 4 ML Dosage Form: Injection Therapeutic Class: Hormonal Therapy / GnRH Agonist Indications: Prostate cancer, endometriosis, uterine fibroids Prescription: Required Global Demand for Leuprolide Injection With increasing cases of prostate cancer and hormonal disorders, medicines like Leuprolide injection are in high demand globally. Healthcare providers in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica import these medicines from reliable pharmaceutical exporters in India such as Ernest Oncology. Eurolide Injection Exporter & Supplier Ernest Oncology is a leading pharmaceutical exporter and distributor of oncology and specialty medicines from India. The company supplies medicines to: • Oncology hospitals • Gynecology clinics • Pharmaceutical wholesalers • Medical procurement companies • Government healthcare tenders • International NGOsWhy Choose Ernest Impex? • Trusted Pharmaceutical Exporter from India • Global supply network covering 100+ countries • GMP compliant medicines • Competitive wholesale pricing • Secure international packaging • Fast global delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth customs clearance for international pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383